Skip to content

Clinical trials

Completed Neoplasm Metastasis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Completed Country / region: South Korea Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20064
20077
20085
20099
20104
20118
20125
20138
20149
20156
20165
20174
20186
20192
20203
20214
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center8
Pfizer7
Bayer6
AstraZeneca5
Novartis Pharmaceuticals5
Sanofi5
Seoul National University Hospital5
GlaxoSmithKline4
Asan Medical Center3
EMD Serono Research & Development Institute, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis98
Neoplasms19
Breast Neoplasms16
Carcinoma, Non-Small-Cell Lung12
Colorectal Neoplasms12
Stomach Neoplasms11
Lung Neoplasms6
Adenocarcinoma4
Pancreatic Neoplasms4
Recurrence4

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.